Giuseppe Giannini, Senior Scientist and Project Leader, Alfasigma SpA
Education:
• Master’s Degree in Chemistry and Pharmaceutical Technology (CTF). Graduated summa cum laude (1986) at University of Bari, Faculty of Pharmacy. Dissertation of two-year experimental thesis on “Synthesis of Cis-Platinum Complex Analogues with Antitumor Activity”.
• Master’s Degree in Pharmacy. Graduated (1988) at University of Bari, Faculty of Pharmacy. Dissertation of one-year experimental thesis on “Biological Activity of Cis-Platinum Derivatives”.
Work Experience:
• Menarini R.S. Pomezia/Italy (1989-98): Medicinal Chemist; Research.
• Sigma-Tau SpA Pomezia/Italy (1998-2017): Medicinal Chemist (Head); Project Leader.
• Leadiant Biosciences S.A. Mendrisio/CH (1998-99): Project leader.
• Alfasigma SpA. Pomezia/Italy (2017 to present): Technology Innovation & External Platforms. Project leader.
Current Research:
• Drug Repurposing via Artificial Intelligence platforms.
• Postbiotic in Rare Diseases.
• Probiotic in Oral Diseases.
Giuseppe Giannini, Senior Scientist and Project Leader, Alfasigma SpA
Education:
• Master’s Degree in Chemistry and Pharmaceutical Technology (CTF). Graduated summa cum laude (1986) at University of Bari, Faculty of Pharmacy. Dissertation of two-year experimental thesis on “Synthesis of Cis-Platinum Complex Analogues with Antitumor Activity”.
• Master’s Degree in Pharmacy. Graduated (1988) at University of Bari, Faculty of Pharmacy. Dissertation of one-year experimental thesis on “Biological Activity of Cis-Platinum Derivatives”.
Work Experience:
• Menarini R.S. Pomezia/Italy (1989-98): Medicinal Chemist; Research.
• Sigma-Tau SpA Pomezia/Italy (1998-2017): Medicinal Chemist (Head); Project Leader.
• Leadiant Biosciences S.A. Mendrisio/CH (1998-99): Project leader.
• Alfasigma SpA. Pomezia/Italy (2017 to present): Technology Innovation & External Platforms. Project leader.
Current Research:
• Drug Repurposing via Artificial Intelligence platforms.
• Postbiotic in Rare Diseases.
• Probiotic in Oral Diseases.